Stay updated on SNDX-5613 with Chemo in AML Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 with Chemo in AML Clinical Trial page.

Latest updates to the SNDX-5613 with Chemo in AML Clinical Trial page
- Check5 days agoChange DetectedA new revision entry labeled v3.6.2 has been added to the record history. The older v3.6.0 entry has been removed.SummaryDifference0.0%

- Check12 days agoChange DetectedDifference0.1%

- Check19 days agoChange DetectedThe study record now shows a new Phase 1b AML trial title and adds sections such as Check who can join, Find Contact Information, Eligibility, Outcome Measures, Study Design, Conditions, Study Description, Study Status, and Study Identification, reflecting the current version 3.6.0; the previous description of adding SNDX-5613 to standard chemotherapy for AML was removed.SummaryDifference0.8%

- Check26 days agoChange DetectedThe footer revision label changed from v3.5.4 to v3.5.5. This reflects a minor maintenance update to the page's history view and does not affect its content.SummaryDifference0.0%

- Check41 days agoChange DetectedOn 2026-05-22, a new Study Status update and a Contacts/Locations section were added, updating how the study's current status and contact details are shown; a prior entry from 2026-05-13 was removed.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision v3.5.4 on 2026-05-13 adds Arms and Interventions and Study Status to the record, with a preceding revision v3.5.3 removed on 2026-04-15.SummaryDifference0.2%

Stay in the know with updates to SNDX-5613 with Chemo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 with Chemo in AML Clinical Trial page.